Xencor reported $727.5M in Equity Capital and Reserves for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Alnylam Pharmaceuticals ALNY:US USD -158223000 90.58M
Amgen AMGN:US USD 3.66B 8M
Arrowhead Research ARWR:US USD 377.04M 21.48M
AstraZeneca AZN:LN USD 37.04B 1.9B
Biogen BIIB:US USD 13.4B 622.4M
Cytokinetics CYTK:US USD -107900000 91.92M
GlaxoSmithKline GSK:LN GBP 10.6B 1.45B
Karyopharm Therapeutics KPTI:US USD -16656000 123.62M
Macrogenics MGNX:US USD 142.01M 19.06M
Novartis NOVN:VX USD 59.34B 1.48B
Regeneron Pharmaceuticals REGN:US USD 22.66B 1.23B
Roche Holding ROG:VX 27.99B 2.8B
Seattle Genetics SGEN:US USD 2.8B 17.99M
Xencor XNCR:US USD 727.5M 4.8M